Cholesterol Archives - Medical Conferences

High-risk and very high-risk patients meet LDL-cholesterol targets with lerodalcibep

Presented By

Prof. Eric Klug, University of the Witwatersrand, South Africa

Trial

Phase 3, LIBerate-HR

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:15

AEGIS-II: ApoA-1 did not reduce MACE in patients with myocardial infarction but may provide benefit in patients with high LDL levels

Presented By

Prof. Michael Gibson, Harvard Medical School, MA, USA

Trial

Phase 3, AEGIS-II

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:26

Gene editing may change the treatment landscape of hypercholesterolaemia

Presented By

Dr Andrew Bellinger, Verve Therapeutics, USA

Trial

Phase 1, heart-1

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:35

REPRIEVE: Mechanisms behind MACE reduction in HIV population on pitavastatin

Presented By

Dr Michael Lu, Massachusetts General Hospital, USA

Trial

Phase 3, REPRIEVE

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:31

Recaticimab may offer a solution for uncontrolled hypercholesterolaemia

Presented By

Dr Xin Du, Beijing Anzhen Hospital, China

Trial

Phase 3, REMAIN-2

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:27

Bempedoic acid benefits statin-intolerant patients at high cardiovascular risk

Presented By

Prof. Steven Nissen, Cleveland Clinic, OH, USA

Trial

Phase 3, CLEAR Outcomes

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:49

Inflammation stronger predictor of MACE than cholesterol levels

Presented By

Prof. Paul Ridker, Brigham and Women's Hospital, MA, USA

Trial

Phase 3, PROMINENT, REDUCE-IT, STRENGTH

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:36

Oral PCSK9 inhibitor significantly lowers LDL-C

Presented By

Prof. Christie Ballantyne, Baylor College of Medicine, TX, USA

Trial

Phase 2

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:30

Pemafibrate fails to reduce cardiovascular events in diabetes but may benefit the liver

Presented By

Dr Aruna Pradhan, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, PROMINENT

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 13:46

Olpasiran leads to dramatic reductions in Lp(a) concentrations

Presented By

Prof. Michelle O´Donoghue, Brigham and Women's Hospital, MA, USA

Trial

Phase 2, OCEAN(a)-DOSE

Conference

AHA 2023

Type

Peer-reviewed article

11 January 2023 12:50

Dietary supplements not effective in lowering LDL-C, use of low-dose statins encouraged

Presented By

Dr Luke Laffin, Cleveland Clinic, OH, USA

Trial

SPORT

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 12:45

No sex differences in lipid-lowering effect and treatment benefit of PCSK9 inhibitors

Presented By

Dr Frederick Rivera, Lincoln Medical Center, NY, USA

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 12:40

Higher LDL-cholesterol levels linked to higher CVD mortality risk in the elderly

Presented By

Dr Zhen Zhou, University of Tasmania, Australia

Trial

ASPREE

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 09:53

TRANSLATE-TIMI 70: Primary endpoint met but safety concerns for vupanorsen

Presented By

Dr Brian Bergmark, Brigham and Women’s Hospital, USA

Trial

Phase 2, TRANSLATE-TIMI 70

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:21

Afbeelding met persoon, muur, vrouw, binnen Automatisch gegenereerde beschrijving

Shortcomings and solutions for the management of young patients with hypercholesterolemia

Expert

Dr Shauna Newton, Massachusetts General Hospital, Boston, MA, USA

Conference

AHA 2021

4 February 2022 00:04

Inclisiran Lowers Cholesterol Across All BMI groups

Expert

Dr Lawrence A. Leiter, Clinical Nutrition and Risk Factor Modification Centre

Conference

AHA 2021

3 February 2022 08:52

Remote healthcare programme improves hypertension and lipid control

Presented By

Dr Alexander Blood, Brigham and Women’s Hospital, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:19

Novel oral PCSK9 inhibitor shows promising results for hypercholesterolaemia

Presented By

Dr Douglas Johns

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:16

The scope of remote healthcare in hypertension and hyperlipidaemia

Expert

Dr Alexander Blood, Brigham and Women’s Hospital, MA, USA

Journal

Physician’s Weekly

Conference

AHA 2021

30 November 2021 10:36

NATURE-PCSK9: Vaccine-like strategy successful in lowering CV events

Presented By

Prof. Brian Ference, University of Cambridge, UK

Trial

NATURE-PCSK9

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:19

2021 ESC Guidelines on Cardiovascular Disease Prevention

Presented By

Prof. Frank Visseren, Guidelines Task Force Chair

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 11:52

Lowering LDL cholesterol in older patients is beneficial

Presented By

Dr Baris Gencer, Brigham and Women’s Hospital, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:54

Safety and efficacy of inclisiran for hypercholesterolemia

Presented By

Prof. R. Scott Wright, Mayo Clinic, USA

Trial

Phase 3, ORION

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:37

Remote risk management programme effective and efficient

Presented By

Prof. Benjamin Scirica, Brigham and Women’s Hospital, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:31

Homozygous FH responds to alirocumab

Presented By

Prof. D. Blom, University of Cape Town, South Africa

Trial

ODYSSEY HoFH

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 14:02

Evinacumab significantly reduces LDL-C in homozygous FH patients

Presented By

Dr F. Raal, University of the Witwatersrand, South Africa

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 13:51

Higher serum levels of eicosapentaenoic acid correlate with reduced CV events

Presented By

Dr D. Bhatt, Brigham and Women's Hospital, USA

Trial

REDUCE-IT EPA analysis

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 13:44

ORION-9: Inclisiran RNAi halves LDL in familial hypercholesterolaemia patients

Presented By

Prof. Frederick Raal, University of the Witwatersrand, South Africa

Trial

Phase 3, ORION-9

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 19:00

New RNAi therapies to reduce triglycerides: 2 studies show favourable results

Presented By

Prof. Christie Ballantyne & Prof. Gerald Watts

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 18:06

Targeting LDL-C <70 mg/dL is better than 100 mg/dL after stroke

Presented By

Prof. Pierre Amarenco, Xavier Bichat Medical School and Denis Diderot University, France

Trial

Treat Stroke to Target

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 15:09

Inclisiran safely halves LDL-Cholesterol

Presented By

Prof. R. Scott Wright, Mayo Clinic, Rochester, USA

Trial

ORION-10

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:51

Patients with polyvascular disease significantly undertreated with lipid lowering therapies

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 15:12